Metraipolis › archive › dc_12fed1e41c07
Efficacy and safety of combined TACE-HAIC and targeted immunotherapy in primary liver cancer with portal vein tumor thrombus — Europe PMC PMID:42376654
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42376654
- DOI
- 10.3389/fonc.2026.1811934
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T11:32:54.295Z
- SHA-256 of the archived text
802e9ace3c9e7161a28be144055c860db4b359f5acd627fa016e90a4b4d4cbc0- Stable URL of this page
https://metraipolis.com/documento/dc_12fed1e41c07
How to cite
Efficacy and safety of combined TACE-HAIC and targeted immunotherapy in primary liver cancer with portal vein tumor thrombus — Europe PMC PMID:42376654 — Europe PMC (en), https://europepmc.org/article/MED/42376654 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_12fed1e41c07 (Metraipolis archive dc_12fed1e41c07, sha256 802e9ace3c9e7161a28be144055c860db4b359f5acd627fa016e90a4b4d4cbc0)
BibTeX
@misc{dc12fed1e41c07,
title = {Efficacy and safety of combined TACE-HAIC and targeted immunotherapy in primary liver cancer with portal vein tumor thrombus — Europe PMC PMID:42376654},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42376654},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_12fed1e41c07; sha256 802e9ace3c9e7161a28be144055c860db4b359f5acd627fa016e90a4b4d4cbc0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42376654. Agents can read the archived copy with the MCP tool read_document.